C-reactive protein and chronic hepatitis C virus infection in diabetic patients

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 12, 2010, Pages 491-496

  Skowroński, Marcin ^a,b   Zozulińska Ziółkiewicz, Dorota ^a   Juszczyk, Jacek ^a   Michalski, Wojciech ^c   Wierusz Wysocka, Bogna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Wielkopolska Center of Pulmonology and Thoracosurgery of Eugenia and Janusz Zeyland   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Diabetes; Hepatitis C virus; Inflammatory markers

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

EID: 79551632352     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1001     Document Type: Article

References (34)

1. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003; 290: 898-904.
2. Braunwald E. Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360-1369. (Pubitemid 27467771)
3. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA. 1998; 279: 1477-1482.
4. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342: 836-843. (Pubitemid 30165206)
5. Natali A, L'Abbate A, Fenannini E. Erythrocyte sedimentation rate, coronary atherosclerosis and cardiac mortality. Eur Heart J. 2003; 24: 639-648.
6. Margolis KL, Manson JE, Greenland R et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005; 165: 500-508.
7. Ruttner MK, Meigs JB, Sullivan L, et al. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study Circulation 2004; 110: 380-385.
8. Kilpatrick ES, Keevil BG, Jagger C, et al. Determinants of raised C-reactive protein concentration in type 1 diabetes. QJM. 2000; 93: 231-236.
9. Jager A, van Hinsbergh VW, Kostense PJ, et al. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study Arterioscler Thromb Vasc Biol. 1999; 19: 3071-3078.
10. Miłosz D, Czupryniak L, Saryusz-Wolska M, et al. [Adiponectinemia, inflammatory process activity, and endothelial dysfunction in patients with type 2 diabetes and acute coronary syndrome with ST elevation in relation to the severity of lesions in the coronary arteries). Pol Arch Med Wewn. 2007; 117: 343-349. Polish.
11. Narita R, Abe S, Kihara Y, et al. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol. 2004; 41: 132-138.
12. Masini M, Campani D, Boggi U, et al. Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care. 2005; 28: 940-941. (Pubitemid 40434503)
13. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991; 13: 372-374.
14. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. JAMA. 2001; 286: 327-334. (Pubitemid 32656163)
15. Oyanagi Y, Takahashi T, Matsui S, et al. Enhanced expression of interleukin-6 in chronic hepatitis C. Liver. 1999; 19: 464-472. (Pubitemid 30019059)
16. Knobler H, Schattner A. TNF-α, chronic hepatitis C and diabetes: a novel triad. QJM. 2005; 98: 1-6.
17. Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J. 2002; 23: 831-834.
18. Herman WA, Sienko A, Korczowska I, Lacka K. Assessment of selected inflammatory markers of acute phase response and their correlations with adrenal androgens and metabolic syndrome in a population of men over the age of 40. Pol Arch Med Wewn. 2009; 119: 704-711.
19. Antonelli A, Ferri C, Fallahi P, et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care. 2005; 28: 2548-2550. (Pubitemid 41384312)
20. Behrendt CE, Ruiz RB. Hyperglycemia among persons with hepatitis C: not the classical diabetic phenotype. Diabetes Res Clin Pract. 2006; 71: 68-74
21. Skowroński M, Zozulińska D, Juszczyk J, Wierusz-Wysocka B. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care. 2006; 29: 750.
22. Shaheen M, Echeverry D, Oblad MG, et al. Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey.[NHANES III] Diabetes Res Clin Pract. 2007; 75: 320-326.
23. Lecube A, Hernández C, Genescà J, et al. Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection. Diabetes Care. 2004; 27: 2669-2675.
24. Lecube A, Hernández C, Genescà J, Simó R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study. Diabetes Care 2006; 29: 1096-1101. (Pubitemid 44115250)
25. Knobler H, Zhornicky T, Sandler A, et al. Tumor necrosis factor-α-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am J Gastroenterol. 2003; 98: 2751-2756. (Pubitemid 38020119)
26. Kalabay L, Nemesánszky E, Csepregi A, et al. Paradoxical alteration of acute-phase protein in patients with chronic hepatitis C treated with IFN-alpha2b. Int Immunol. 2003; 16: 51-54.
27. Shima M, Nakao, Kato Y, et al. Comparative study of C-reactive protein in chronic hepatitis B and chronic hepatitis C. Tohoku J Exp Med. 1996; 178: 287-297.
28. Floris-Moore M, Howard AA, Lo Y, et al. Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patients Care STDS. 2007; 21: 479-491.
29. Shim WS, Kim HJ, Kang ES, et al. The association of total and differential white blood cell count with the metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract. 2006; 73: 284-291.
30. Danesh J, Wheeler JG, Hirchfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004; 350: 1387-1397.
31. Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008; 359: 1897-1908.
32. Völzke H, Schwahn C, Wolff B, et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis. 2004; 174: 99-103.
33. Dolganiuc A, Kodys K, Kopasz A, et al. Hepatitis C virus core and non-structural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol. 2003; 170: 5615-5624.
34. Reiser M, Marousis CG, Nelson DR, et al. Serum interleukin 4 and interieukin 10 in patients with chronic hepatitis C virus infection. J Hepatol. 1997; 26: 471-478.